Risankizumab for Ulcerative Colitis
JAMA Author Interviews
00:00
Intro
Exploring the latest FDA-approved medications and treatment options for patients with moderate to severe ulcerative colitis, aiming to induce and maintain remission to prevent inflammation reactivation.
Transcript
Play full episode
